Foreword
Partnerships
A pill for growth
The pharma industry is treading a new path for sustaining growthpartnerships Escalating RD costs tough regulations and price controls continue to trouble the industry Further a severe blockbuster drought patent expiries and anaemic drug pipelines have only added to the industrys woes Innovation did provide hope but even that has become a high
